The aging of our societies leads to a higher prevalence of multimorbidity, and therefore polypharmacy, which often results in inappropriate drug treatment in older adults.

Fit fOR The Aged’s (FORTA’s) positive impact on the quality of medications and relevant clinical outcomes has been shown.

In this work, seven new country/region-specific FORTA lists, as well as a new overarching EURO-FORTA List, were developed.